Intra-nasal esketamine induced psychotic disorder in a post COVID-19 major depressive episode: A case report

Encephale. 2024 Oct;50(5):583-584. doi: 10.1016/j.encep.2023.05.001. Epub 2023 May 10.
No abstract available

Keywords: COVID-19; Esketamine; Idées suicidaires; Induites par une substance; Major depressive disorder; Neuropsychiatrie; Neuropsychiatry; Psychoses; Psychosis; Substance-induced; Suicidal ideation; Troubles dépressifs majeurs.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Intranasal*
  • COVID-19* / complications
  • Depressive Disorder, Major* / drug therapy
  • Depressive Disorder, Major* / psychology
  • Female
  • Humans
  • Ketamine* / administration & dosage
  • Ketamine* / adverse effects
  • Male
  • Middle Aged
  • Psychoses, Substance-Induced / diagnosis
  • Psychoses, Substance-Induced / etiology
  • Psychoses, Substance-Induced / psychology
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / psychology
  • SARS-CoV-2

Substances

  • Ketamine
  • Esketamine